Xeris Biopharma Holdings, Inc.

Ownership Transactions Reported by 17 Insiders

Symbol
XERS on Nasdaq
Industry
Pharmaceutical Preparations
Location
1375 West Fulton Street, Suite 1300, Chicago, IL

Insiders trading volume in the past year

Xeris Biopharma Holdings, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Kevin McCulloch President and Chief Operating Officer $14.3M +$109K +0.77% Oct 2, 2025
Beth Hecht Chief Legal Officer and Corporate Secretary $9.89M -$341K -3.33% Nov 11, 2025
John Johnson Director $7.31M -$786K -9.71% Aug 13, 2025
Paul R. Edick Chairman and Chief Executive Officer, Director $7.15M Jan 31, 2024
Steven Pieper Chief Financial Officer $5.05M Jan 31, 2025
John Patrick Shannon Jr Chief Executive Officer and Director, Director $4.23M -$173K -3.94% Nov 13, 2025
Jeffrey W. Sherman Director $1.71M -$335K -16.4% Aug 28, 2025
Garheng Kong Director $1.66M Jun 4, 2025
Steven Prestrelski Chief Scientific Officer $1.35M Jan 31, 2023
Marla Persky Director $1.27M -$120K -8.59% Sep 11, 2025
Dawn Halkuff Director $1.27M -$309K -19.6% Aug 12, 2025
Kennedy Barbara Bormann Director $1.22M Jun 4, 2025
Kenneth Erland Johnson Senior Vice President, Global Development and Medical Affairs $1.14M Jan 31, 2025
Anh Tu Nguyen Chief Medical Officer $1.09M Feb 25, 2025
James Aloysius Brady Director $543K Mar 28, 2025
John P. Schmid Director $311K Aug 12, 2024
Ricki Louise Fairley Director $258K Jun 5, 2024

Recent Insider Transactions by Companies or Individuals for Xeris Biopharma Holdings, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.